Iguchi Hiroyoshi, Oda Masaya, Yamazaki Hitoshi, Yoshimura Kazunori, Ando Wataru, Yokomori Hiroaki
Department of Radiology, Kitasato University Medical Center, Saitama, Japan.
Med Mol Morphol. 2014 Jun;47(2):90-9. doi: 10.1007/s00795-013-0048-6. Epub 2013 Aug 15.
Although aquaporins (AQPs) in normal hepatobiliary system have been studied, little is known about AQP localization and changes in the hepatic microvascular system including sinusoids in cholestatic liver. The present study aimed to clarify the localization of AQP-1 in the microvessels in normal human liver and in primary biliary cirrhosis (PBC). Human normal liver (control) and PBC liver specimens were obtained. Immunohistochemistry, Western blotting, in situ hybridization (ISH) and electron microscopic examination for AQP-1 were conducted. In control liver and stages I-II PBC liver, AQP-1 immunoreactivity was mainly localized in portal venules, hepatic arterioles and bile ducts in the portal tract, but was hardly detected in the sinusoids. However, AQP-1 expression was enhanced in the proliferated bile ductules in PBC. In stages III-IV PBC liver tissues, AQP-1 was aberrantly expressed in proliferated arterial capillaries opening into the sinusoids at the peripheral edge of regenerating hepatic nodules and in the fibrotic septa. Overexpression of AQP-1 at protein and mRNA levels was demonstrated by Western blot and ISH, respectively. Angiogenetic and fibrotic responses are probably induced by AQP-1, leading to enhanced pouring of arterial blood into the sinusoids; thus, contributing to progression of portal hypertension in PBC.
尽管已经对正常肝胆系统中的水通道蛋白(AQP)进行了研究,但对于胆汁淤积性肝病中包括肝血窦在内的肝微血管系统中AQP的定位和变化却知之甚少。本研究旨在阐明水通道蛋白-1(AQP-1)在正常人类肝脏和原发性胆汁性肝硬化(PBC)微血管中的定位。获取了人类正常肝脏(对照)和PBC肝脏标本。对AQP-1进行了免疫组织化学、蛋白质印迹、原位杂交(ISH)和电子显微镜检查。在对照肝脏和I-II期PBC肝脏中,AQP-1免疫反应性主要定位于汇管区的门静脉小支、肝动脉小支和胆管,但在肝血窦中几乎检测不到。然而,AQP-1在PBC中增生的胆小管中表达增强。在III-IV期PBC肝脏组织中,AQP-1在再生肝结节周边边缘通向肝血窦的增生动脉毛细血管和纤维化间隔中异常表达。蛋白质印迹和ISH分别证实了AQP-1在蛋白质和mRNA水平的过表达。AQP-1可能诱导血管生成和纤维化反应,导致更多动脉血流入肝血窦;因此,促进了PBC门静脉高压的进展。